Results 131 to 140 of about 84,355 (327)

Clinical periodontal diagnosis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi   +5 more
wiley   +1 more source

A case of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma

open access: yesJEADV Clinical Practice
A 65‐year‐old Japanese woman with primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma, a rare type with a poor prognosis, is presented.
Tomomichi Shimizu   +9 more
doaj   +1 more source

Copanlisib in combination with rituximab and bendamustine for transplant‐ineligible relapsed/refractory diffuse large B‐cell lymphoma patients: Results from the phase II multicentre FIL Copa‐BR trial from Fondazione Italiana Linfomi (FIL)

open access: yesBritish Journal of Haematology, EarlyView.
A phase II, single‐arm, multicentre trial was conducted by Fondazione Italiana Linfomi (FIL) to investigate the combination of copanlisib plus rituximab and bendamustine (copa‐BR) in transplant‐ and chimeric antigen receptor (CAR)‐T‐ineligible relapsed/refractory (R/R) diffuse large B‐cell lymphoma (DLBCL). Thirty‐seven patients were enrolled.
Mattia Novo   +24 more
wiley   +1 more source

Large‐cell transformation of mycosis fungoides: Patterns of care and patient outcomes

open access: yesBritish Journal of Haematology, EarlyView.
Large‐cell transformation of mycosis fungoides is rare with poor prognosis. Presenting over 20 years of data, this retrospective study of 83 patients demonstrated a median overall survival (mOS) of 3.5 years. However, prognostic differences in three clinical subgroups were suggested: unifocal, multifocal, extra‐cutaneous (mOS: 4.6, 2.5, 1.1 years ...
Philippa Johnstone   +9 more
wiley   +1 more source

Cutaneous involvement in angioimmunoblastic T-cell lymphoma

open access: yesIndian Journal of Dermatology, 2010
Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive non-Hodgkin′s nodal peripheral T-cell lymphoma characterized by general lymphadenopathy, night sweats, fever, hepatosplenomegaly, polyclonal hypergammaglobulinemia, and cutaneous ...
Papadavid Evangelia   +5 more
doaj  

Secondary malignancies after chronic myeloid leukaemia upon TKI treatment: Population trends and outcomes

open access: yesBritish Journal of Haematology, EarlyView.
A retrospective study from 11 institutions was performed in 139 chronic myeloid leukaemia (CML) patients with secondary malignancies. The median ages at diagnosis of CML and secondary malignancy were 51 years (range, 13–88 years) and 53 years (range, 18–91 years). After a median follow‐up of 85 months, the median time from diagnosis of CML to secondary
Yingling Zu   +17 more
wiley   +1 more source

Breast implant-associated anaplastic large cell lymphoma: A review and assessment of cutaneous manifestations

open access: yesInternational Journal of Women's Dermatology, 2017
One newly recognized form of T-cell lymphoma is breast implant-associated anaplastic large cell lymphoma (biALCL), which appears in close proximity to breast implants. The number of reported cases of biALCL is increasing and warrants careful attention by
N. Shahriari, MD   +2 more
doaj  

Clinical manifestations of intrathoracic cutaneous T-cell lymphoma [PDF]

open access: bronze, 1985
Lawrence M. Stokar   +5 more
openalex   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. [PDF]

open access: yes, 2020
Since 2013, the International Union of Immunological Societies (IUIS) expert committee (EC) on Inborn Errors of Immunity (IEI) has published an updated phenotypic classification of IEI, which accompanies and complements their genotypic classification ...
Ailal, Fatima   +18 more
core  

Home - About - Disclaimer - Privacy